ANNOVIS BIO INC. COMMON STOCK
7.4100
13-11月-24 15:30:00
15 分の遅延
株式
-0.1300
-1.72%
本日の幅
7.3600 - 7.7700
ISIN
N/A
ソース
NYSE
-
12 11 2024 07:00:01 提供 Nasdaq GlobeNewswire
-
Annovis Bio Reports Third Quarter Financial Results and Provides Business Update
11 11 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio Appoints Matthew Peterson, Ph.D., as Senior Clinical Scientist
07 11 2024 07:00:01 提供 Nasdaq GlobeNewswire
-
Annovis to Highlight Buntanetap's Alzheimer's Research Progress with Presentations at CTAD 2024
22 10 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
FDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer’s Studies, Paving the Way to NDAs
15 10 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
03 10 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
02 10 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
30 9 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference
05 9 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio Reports Second Quarter Financial Results and Provides Business Update
15 8 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
Annovis’ Lead Compound Enhances Cognition Synergistically with GLP-1 Agonist
06 8 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio Secures U.S. Patent for Treatment of Acute Traumatic Brain Injury with Buntanetap
24 7 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio Receives FDA Approval to Transition to New Crystal Form of Buntanetap
16 7 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio Welcomes Four New Executives to Strengthen Leadership Team
09 7 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap
27 6 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio Files Patent for New Composition of Matter for Buntanetap
26 6 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson’s Disease Data
25 6 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
18 6 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Annovis Bio’s Buntanetap Found Safe and Effective in High-Risk Alzheimer's Patients
11 6 2024 07:00:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >